Arcus Biosciences RCUS
NYSE RCUS
$25.95 +0.30 (+1.17%)
As of: Sep 30, 2026 · 9:47 AM EDT

Arcus Biosciences (RCUS) Revenue (2017 - 2026)

Updated

Arcus Biosciences (RCUS) posted Revenue of $41 million for Q2 2026, down 74.4% from $160 million a year earlier but up 141.2% from the prior quarter.

Analysis

Arcus Biosciences (RCUS) Revenue (2017 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Revenue at Arcus Biosciences was $117 million, down 55.3% year-over-year; for FY2025, it came in at $247 million, down 4.3% from FY2024.

  • Annual Revenue shows a five-year compound annual growth rate of 25.9% (FY2020 to FY2025).
  • In prior years, Arcus Biosciences' Revenue was $258 million in FY2024 (+120.5%), $117 million in FY2023 (+4.5%), $112 million in FY2022 (-70.8%) and $383 million in FY2021 (+391.0%).
  • Quarterly Revenue has run from a low of $9.46 million in Q3 2021 to a high of $354.62 million in Q4 2021 over five years.
  • On a year-over-year basis, Revenue increased in three of the last eight quarters, with growth averaging 16.4%.
  • The strongest year-over-year quarter for Revenue in the past five years was Q1 2024, with growth of 480.0%; the weakest was Q4 2022, with a decline of 90.4%.
  • According to Business Quant data, Revenue for the three prior quarters was $17 million (Q1 2026), $33 million (Q4 2025) and $26 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 25.31 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 16.99 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 16.61 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 14.41 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 15.38 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 10.05 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 7.80 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 15.03 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.33 Bn
10 Arcus Biosciences 3.18 Bn -157.19 Mn - 41.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 41.00 Mn
Mar 31, 2026 17.00 Mn
Dec 31, 2025 33.00 Mn
Sep 30, 2025 26.00 Mn
Jun 30, 2025 160.00 Mn
Mar 31, 2025 28.00 Mn
Dec 31, 2024 26.00 Mn
Sep 30, 2024 48.00 Mn
Jun 30, 2024 39.00 Mn
Mar 31, 2024 145.00 Mn
Dec 31, 2023 31.00 Mn
Sep 30, 2023 32.00 Mn
Jun 30, 2023 29.00 Mn
Mar 31, 2023 25.00 Mn
Dec 31, 2022 34.00 Mn
Sep 30, 2022 33.00 Mn
Jun 30, 2022 27.00 Mn
Mar 31, 2022 18.00 Mn
Dec 31, 2021 354.62 Mn
Sep 30, 2021 9.46 Mn
API Access

Arcus Biosciences Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=RCUS&period=max&api_key=YOUR_API_KEY